• Clinical Insights: September 13, 2019

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more.   New Drug Approval Ibsrela® (tenapanor) – New Drug Approval – September 12, 2019 – Ardelyx, Inc., announced that the U.S. Food and Drug Administration has approved Ibsrela®… Read more »

  • 340B Insider – August 2019

                    Welcome to the August edition of RxStrategies’ 340B Insider, a concise communication to provide a quick highlight of updates from RxStrategies’ view. Visit our website to read more.           RECAP: 340B COALITION SUMMER CONFERENCE It was great to connect with so many of our clients and industry leaders… Read more »

  • Clinical Insights: August 29, 2019

    Welcome to RxStrategies Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more.   New Drug Approval Nourianz™ (istradefylline) – New Drug Approval – August 27, 2019 – The U.S. Food and Drug Administration approved Nourianz™ (istradefylline) tablets as an add-on treatment… Read more »

  • Meet Us at Cardinal Health’s RBC 2019

    Todd Hudnall and Skip Devanny will represent RxStrategies at Cardinal Health’s RBC 2019 in Nashville, July 17-20. Learn more about RBC by visiting their site. Contact us to connect during the conference, and stop by booth 118 to learn about how our comprehensive solutions help keep your 340B program on the right track.

  • Stay on Top of 340B this Summer

    We are looking forward to connecting with you during the 340B Coalition Summer Conference being held July 15-17 in Washington, D.C. RxStrategies is proud to be a Pinnacle Sponsor for the event. Our team will be connecting with key leaders to discuss 340B comprehensive solutions, and share ideas on how to keep your 340B program on the right… Read more »

  • The Future of Policy at NACHC 2019

      March 27 – 30, RxStrategies representatives Rhodie Smith and Justin Rolling will attend the 2019 Policy and Issues Forum hosted by the National Association of Community Health Centers (NACHC). As one of the largest conferences on health policy, people from all corners of the administration and operations of health care will attend. The priorities… Read more »

  • 340B Program Compliance. Achieve More With Intuitive Solutions.

    It was great to connect with industry leaders during the 15th Annual 340B Coalition Winter Conference! As a pharmacist, clinic director, or C-suite executive, one of your top priorities is to provide safe and cost-effective care and ensure regulatory compliance.   RxStrategies understands the complexities of the 340B program and recognizes the importance of open communication… Read more »